Grace Vulic
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Grace Vulic has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Hsiang-Yin Hsueh
The Ohio State University Wexner Medical Center 1 Department of Internal Medicine, Division of Gastroenterology, Hepatology, and Nutrition Columbus, Ohio
25 shared publications - Kristyn Gumpper-Fedus
Department of Internal Medicine, Division of Gastroenterology, Hepatology, and Nutrition, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA
25 shared publications - Zobeida Cruz-Monserrate
Department of Internal Medicine, Division of Gastroenterology, Hepatology, and Nutrition, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA
25 shared publications - Alexus Liette
The Ohio State University Wexner Medical Center 1 Department of Internal Medicine, Division of Gastroenterology, Hepatology, and Nutrition Columbus, Ohio
24 shared publications - Ericka Vélez-Bonet
The Ohio State University Wexner Medical Center 1 Department of Internal Medicine, Division of Gastroenterology, Hepatology, and Nutrition Columbus, Ohio
24 shared publications - Fouad Choueiry
The Ohio State University 2 The Comprehensive Cancer Center Columbus, Ohio
24 shared publications
Latest Publications
- Open Access
- 12 September 2026
- Published by Elsevier in Cancer Letters
- Vol. 660
Lack of tumor-derived LCN2 sensitizes pancreatic cancer cells to ferroptosis induction
- 12 September 2026
- Published by Elsevier in Cancer Letters
- Vol. 660
Open AccessLack of tumor-derived LCN2 sensitizes pancreatic cancer cells to ferroptosis induction
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from Ketogenic Diet Prevents Obesity-Associated Pancreatic Cancer Independent of Weight Loss and Induces Pancreatic Metabolic Reprogramming
Macronutrient composition and ingredient content of experimental diets, including matched low-fat controls for HFD, DIO, and KD formulations.
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from Ketogenic Diet Prevents Obesity-Associated Pancreatic Cancer Independent of Weight Loss and Induces Pancreatic Metabolic Reprogramming
Macronutrient composition and ingredient content of experimental diets, including matched low-fat controls for HFD, DIO, and KD formulations.
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 6 from Ketogenic Diet Prevents Obesity-Associated Pancreatic Cancer Independent of Weight Loss and Induces Pancreatic Metabolic Reprogramming
Pancreas weight in control and KrasG12D mice across dietary conditions, demonstrating a decrease following KD.
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 6 from Ketogenic Diet Prevents Obesity-Associated Pancreatic Cancer Independent of Weight Loss and Induces Pancreatic Metabolic Reprogramming
Pancreas weight in control and KrasG12D mice across dietary conditions, demonstrating a decrease following KD.
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 5 from Ketogenic Diet Prevents Obesity-Associated Pancreatic Cancer Independent of Weight Loss and Induces Pancreatic Metabolic Reprogramming
Representative H&E liver histology showing genotype-dependent differences between control and KrasG12D mice under varying dietary fat conditions.
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 5 from Ketogenic Diet Prevents Obesity-Associated Pancreatic Cancer Independent of Weight Loss and Induces Pancreatic Metabolic Reprogramming
Representative H&E liver histology showing genotype-dependent differences between control and KrasG12D mice under varying dietary fat conditions.
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 9 from Ketogenic Diet Prevents Obesity-Associated Pancreatic Cancer Independent of Weight Loss and Induces Pancreatic Metabolic Reprogramming
Tumor growth, body weight, glucose tolerance, and ketone levels in a non-obese orthotopic PDAC model, showing no effect of KD on tumor growth.
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 9 from Ketogenic Diet Prevents Obesity-Associated Pancreatic Cancer Independent of Weight Loss and Induces Pancreatic Metabolic Reprogramming
Tumor growth, body weight, glucose tolerance, and ketone levels in a non-obese orthotopic PDAC model, showing no effect of KD on tumor growth.
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 from Ketogenic Diet Prevents Obesity-Associated Pancreatic Cancer Independent of Weight Loss and Induces Pancreatic Metabolic Reprogramming
Pancreatic β-hydroxybutyrate concentrations in KrasG12D mice across diet groups following KD intervention.
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 from Ketogenic Diet Prevents Obesity-Associated Pancreatic Cancer Independent of Weight Loss and Induces Pancreatic Metabolic Reprogramming
Pancreatic β-hydroxybutyrate concentrations in KrasG12D mice across diet groups following KD intervention.
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 10 from Ketogenic Diet Prevents Obesity-Associated Pancreatic Cancer Independent of Weight Loss and Induces Pancreatic Metabolic Reprogramming
Pancreatic lesion severity in KrasG12D mice selected for metabolomic analysis across diet groups.
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 10 from Ketogenic Diet Prevents Obesity-Associated Pancreatic Cancer Independent of Weight Loss and Induces Pancreatic Metabolic Reprogramming
Pancreatic lesion severity in KrasG12D mice selected for metabolomic analysis across diet groups.
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 8 from Ketogenic Diet Prevents Obesity-Associated Pancreatic Cancer Independent of Weight Loss and Induces Pancreatic Metabolic Reprogramming
KD effects in an orthotopic PDAC model, showing no inhibition of tumor growth regardless of weight loss.
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 8 from Ketogenic Diet Prevents Obesity-Associated Pancreatic Cancer Independent of Weight Loss and Induces Pancreatic Metabolic Reprogramming
KD effects in an orthotopic PDAC model, showing no inhibition of tumor growth regardless of weight loss.
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 from Ketogenic Diet Prevents Obesity-Associated Pancreatic Cancer Independent of Weight Loss and Induces Pancreatic Metabolic Reprogramming
Glucose tolerance by AUC at baseline and after 15 weeks, showing increased glucose intolerance following DIO compared to LFD.
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 from Ketogenic Diet Prevents Obesity-Associated Pancreatic Cancer Independent of Weight Loss and Induces Pancreatic Metabolic Reprogramming
Glucose tolerance by AUC at baseline and after 15 weeks, showing increased glucose intolerance following DIO compared to LFD.
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 7 from Ketogenic Diet Prevents Obesity-Associated Pancreatic Cancer Independent of Weight Loss and Induces Pancreatic Metabolic Reprogramming
Pathological distribution and disease burden indicating suppression of PDAC development by KD in obesity-associated models.
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 7 from Ketogenic Diet Prevents Obesity-Associated Pancreatic Cancer Independent of Weight Loss and Induces Pancreatic Metabolic Reprogramming
Pathological distribution and disease burden indicating suppression of PDAC development by KD in obesity-associated models.